02138 EC HEALTHCARE
- 1.390
- +0.050+3.73%
EC HEALTHCARE News
MedicalHealth (02138.HK) appoints EY as new auditor
Gelonghui, March 19 | Medical Healthcare (02138.HK) announced that due to the failure of the company and KPMG to agree on audit fees for the financial year ending March 31, 2024, KPMG has resigned as the company's auditor, effective March 19, 2024. Based on the recommendation of the Audit Committee, the Board of Directors resolved to appoint Ernst & Young as the company's new auditor with effect from March 19, 2024 to fill the temporary vacancy after KPMG's resignation. EY's term of office will last until the end of the company's next Annual General Meeting of Shareholders.
Changes in Hong Kong stocks | MedicalHealth (02138) surged more than 15%. Overall sales for the quarter ending 2023 are expected to be no less than HK$1.1 billion, up no less than 7% year over year
Medical Thinking Health (02138) surged more than 15%. As of press release, it rose 15.69% to HK$1.77, with a turnover of HK$5.35 million.
Changes in Hong Kong stocks | MedicalHealth (02138) rose more than 26% and sales are expected to increase by no less than 7% year-on-year in the third quarter of FY24
Medical Thinking Health (02138) rose by more than 26%. As of press release, it rose 21.24% to HK$1.37, with a turnover of HK$8.6623 million.
It's Down 32% But EC Healthcare (HKG:2138) Could Be Riskier Than It Looks
Unfortunately for some shareholders, the EC Healthcare (HKG:2138) share price has dived 32% in the last thirty days, prolonging recent pain. For any long-term shareholders, the last month ends a ye
EC Healthcare's Overall Sales Volume Rises 7% in Q4 2023
The overall sales of non-hospital medical service provider EC Healthcare (HKG:2138) rose 7% in the fourth quarter of 2023. Included in the sales volume are medical services, and aesthetic medical and
Medical Thinking Health (02138.HK)'s overall sales volume for the three months ended 31 December exceeded HK$1.1 billion, up more than 7% year on year
Gelonghui, January 23 | Medical Health (02138.HK) announced that for the three months ending December 31, 2023, the Group is expected to record: (i) overall sales of no less than HK$1.1 billion during the quarter, an increase of no less than 7% over the same period last year; (ii) sales of medical services provided by the Group during the quarter increased by no less than 6% over the same period last year; (iii) the sales volume of the Group's aesthetic medicine, beauty and wellness services in Hong Kong and Macau during the quarter increased by no less than 5% compared to the same period last year; (iv) the sales volume of the Group's aesthetic medicine, beauty and wellness services in mainland China during the quarter compared to the same period last year; (iv) the sales volume of the Group's aesthetic medicine, beauty and wellness services in mainland China during the quarter compared to the same period last year; (iv) the sales volume of the Group's aesthetic medicine, beauty and wellness services in main
EC Healthcare Further Acquires Stake in Pangenia for HK$33.2 Million
EC Healthcare (HKG:2138) further acquired 12.4% of British Virgin Islands-incorporated Pangenia for a consideration of HK$33.2 million. The company already bought 42.9% of Pangenia through the acquisi
MedicalHealth (02138) plans to spend HK$33.2 million to further acquire 12.38% of Xinya's shares
MedicalHealth (02138) announced that it has acquired Active Compass Limit...
Medical and aesthetic stocks surged out of the Times Angel (06699) and rose 9.1%, CITIC Securities indicates that sector valuations are already attractive
Jinwu Financial News | The medical and aesthetic sector came out strong, with Times Angel (06699) up 9.1%, FuRui Medical Technology (01696) up 4.84%, Sansheng Pharmaceutical (01530) up 4.03%, Perfect Healthcare (01830) up 3.79%, MODERN DENTAL (03600) up 3.7%, Medical Thinking Health (02138) up 3.28%, and Giant Biotech (02367) up 3.12%. CITIC Securities said that “still water”: the medical and aesthetic industry is being pressured in stages due to multiple factors such as purchasing power and willingness to spend, and the growth rate is slowing down. “Deep flow”: upstream and downstream leaders continue to grow at a high rate, market
Don't Race Out To Buy EC Healthcare (HKG:2138) Just Because It's Going Ex-Dividend
It looks like EC Healthcare (HKG:2138) is about to go ex-dividend in the next 3 days. The ex-dividend date occurs one day before the record date which is the day on which shareholders need to be on t
醫思健康：2023/24半年度業績報告
Investors Don't See Light At End Of EC Healthcare's (HKG:2138) Tunnel And Push Stock Down 29%
Unfortunately for some shareholders, the EC Healthcare (HKG:2138) share price has dived 29% in the last thirty days, prolonging recent pain. For any long-term shareholders, the last month ends a ye
Changes in Hong Kong stocks | Yisi Health (02138) fell nearly 5%, medium-term net profit fell 91.7% year on year
Yisi Health (02138) fell nearly 5%. As of press release, it was down 4.31% to HK$2, with a turnover of HK$4,604,600.
EC Healthcare Buys Stake in Medical Laboratory Testing Company
EC Healthcare (HKG:2138) subsidiary Jade Master International purchased the entire stake in Active Compass and Victor Mind International, and in turn an aggregate 42.88% stake in Pangenia Group for HK
Selected Announcements｜Alibaba Pictures completed the share acquisition of Damai.com; MODERN DENTAL's revenue for the first three quarters increased by about 13% year-on-year to HK$2,363 billion
PhysicsHealth plans to acquire 42.88% of Xinya's shares for HK$115 million to promote the expansion of the medical laboratory testing market; on November 30, Tencent Holdings spent HK$400 million to repurchase 1.24 million shares.
PhysicsHealth (02138.HK) plans to acquire 42.88% of Xinya's shares for HK$115 million to promote expansion of the medical laboratory testing market
Gelonghui (02138.HK) announced that on November 30, 2023, the company, the buyer (Jade Master International Limited, an indirect wholly-owned subsidiary of the company), Mason Group Holdings Co., Ltd. and the seller (Full Joyous International Limited, a wholly-owned subsidiary of Mason) entered into this agreement. Under this, the seller agreed to sell shares, which is equivalent to all the shares of various target companies, while jointly holding Xinya Issued share capital 42.88
Yisi Health (02138) will pay an interim dividend of HK$0.005 per share on January 19, 2024
Yisi Health (02138) announced that the company will pay an interim dividend of 0 per share on January 19, 2024...
EC HEALTHCARE To Go Ex-Dividend On December 28th, 2023 With 0.005 HKD Dividend Per Share
November 30th - $EC HEALTHCARE(02138.HK)$ is trading ex-dividend on December 28th, 2023. Shareholders of record on December 29th, 2023 will receive 0.005 HKD dividend per share on January 19th, 20
EC Healthcare Records 79% Fall in Fiscal H1 Profit
EC Healthcare (HKG:2138) reported a 79.6% decrease in net profit after tax for the six months through September 2023 to HK$21.4 million, from a profit of HK$105.2 million in the year-ago period. Basic
Yisi Health (02138.HK)'s total mid-term revenue increased 12% to HK$2,121.3 billion with interest of HK0.5 cents per share
GLONGHUI November 30丨PhysicsHealth (02138.HK) announced interim results. For the six months ended September 30, 2023, sales were HK$2,197 billion, up 17.7% year on year; total revenue increased 12.0% year over year to HK$2,121.3 billion, mainly driven by the gradual return of mainland tourists after the resumption of cross-border tourism between Hong Kong and mainland China in early 2023; profit before interest, tax, depreciation and amortization decreased 22.7% year over year to HK$208.7 million, but increased by 30.1% compared with the second half of the fiscal year 2023 ; Net profit after tax decreased year-on-year
Analysis
Price Target
No Data
